These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16219969)

  • 1. Anti-inflammatory action of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and the prevention of diabetes mellitus in obese patients with hypertension.
    Mascitelli L; Pezzetta F
    Hong Kong Med J; 2005 Oct; 11(5):424. PubMed ID: 16219969
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity hypertension: the rationale for renin-angiotensin system blockade.
    Chan NN; Tong PC; Kong AP; Chan JC
    Hong Kong Med J; 2005 Jun; 11(3):217-20. PubMed ID: 15951590
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms.
    van der Zijl NJ; Moors CC; Goossens GH; Blaak EE; Diamant M
    Diabetes Obes Metab; 2012 Jul; 14(7):586-95. PubMed ID: 22226145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatment strategies for patients with hypertension and insulin resistance.
    Kurtz TW
    Am J Med; 2006 May; 119(5 Suppl 1):S24-30. PubMed ID: 16563944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-diabetic effect of blockade of the renin-angiotensin system.
    Ando K; Fujita T
    Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of arterial hypertension in obese patients.
    Wenzel UO; Benndorf R; Lange S
    Semin Nephrol; 2013 Jan; 33(1):66-74. PubMed ID: 23374895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of angiotensin receptor blockers in diabetic nephropathy.
    Sharma AM; Weir MR
    Postgrad Med; 2011 May; 123(3):109-21. PubMed ID: 21566421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 11. Is there a rationale for angiotensin blockade in the management of obesity hypertension?
    Sharma AM
    Hypertension; 2004 Jul; 44(1):12-9. PubMed ID: 15173127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance, diabetes, hypertension, and renin-angiotensin system inhibition: reducing risk for cardiovascular disease.
    Fonseca VA
    J Clin Hypertens (Greenwich); 2006 Oct; 8(10):713-20; quiz 721-2. PubMed ID: 17028485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic safety of antihypertensive drugs: myth versus reality.
    Stas S; Appesh L; Sowers J
    Curr Hypertens Rep; 2006 Oct; 8(5):403-8. PubMed ID: 16965727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
    Middeke M
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
    [No Abstract]   [Full Text] [Related]  

  • 15. Renin-angiotensin-system blockade in the prevention of diabetes.
    Ostergren J
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S13-21. PubMed ID: 17320999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antihypertensive agents on the development of type 2 diabetes mellitus.
    Stump CS; Hamilton MT; Sowers JR
    Mayo Clin Proc; 2006 Jun; 81(6):796-806. PubMed ID: 16770980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system.
    Cooper ME; Tikellis C; Thomas MC
    J Hypertens Suppl; 2006 Mar; 24(1):S57-63. PubMed ID: 16601575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for special populations: diabetes mellitus and the metabolic syndrome.
    Sowers JR
    Am J Hypertens; 2003 Nov; 16(11 Pt 2):41S-45S. PubMed ID: 14625160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V; Buksa M; Loza V; Kulic M
    Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.